Schedule 13G ownership disclosure

Aura Biosciences Inc

Common Stock, $0.00001 par value per share · CUSIP: 05153U107

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Frazier Life Sciences Public Fund, L.P.

    Shares: 4,032,060.00 · Class: 6.3%

  • FHMLSP, L.P.

    Shares: 4,032,060.00 · Class: 6.3%

  • FHMLSP, L.L.C.

    Shares: 4,032,060.00 · Class: 6.3%

  • Frazier Life Sciences X, L.P.

    Shares: 128,520.00 · Class: 0.2%

  • FHMLS X, L.P.

    Shares: 128,520.00 · Class: 0.2%

  • FHMLS X, L.L.C.

    Shares: 128,520.00 · Class: 0.2%

  • Frazier Life Sciences XI, L.P.

    Shares: 342,210.00 · Class: 0.5%

  • FHMLS XI, L.P.

    Shares: 342,210.00 · Class: 0.5%

  • FHMLS XI, L.L.C.

    Shares: 342,210.00 · Class: 0.5%

  • Frazier Life Sciences XII, L.P.

    Shares: 597,210.00 · Class: 0.9%

  • FHMLS XII, L.P.

    Shares: 597,210.00 · Class: 0.9%

  • FHMLS XII, L.L.C.

    Shares: 597,210.00 · Class: 0.9%

  • James N. Topper

    Shares: 128,520.00 · Class: 0.2%

  • Patrick J. Heron

    Shares: 128,520.00 · Class: 0.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001231919-26-000155
Form type
SCHEDULE 13G/A
Filer
Aura Biosciences, Inc.
CIK
CIK 1501796
Filed
Feb 13, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub